4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002328
Chief Commercial Officer acquired 2,509 shares (grant or award)
- Chief Commercial Officer gave up 544 shares (to pay taxes)
- Chief Commercial Officer acquired 995 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moat Ross · Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-15 | Grant or award : show line 1 in the form | +963 | $11.49 | $11,065 | 4,345 | D |
| 2022-01-15 | Grant or award : show line 2 in the form | +1,546 | $9.63 | $14,888 | 5,891 | D |
| 2022-03-16 | Exercise or conversion : show line 3 in the form | +995 | 6,886 | D | ||
| 2022-03-16 | Shares withheld for taxes : show line 4 in the form | −544 | $10.13 | $5,511 | 6,342 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-16 | Exercise or conversion : show line 5 in the form Restricted Share Unit | −995 | 2,982 | D |
Loading xslF345X03/edgar.xml…